July 19, 2023 July 19, 2023Categories Announcements News StoriesThe Summer 2023 advocacy blog, Considering Clinical Trials, is now available
February 15, 2023 February 15, 2023Categories AnnouncementsA participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
December 19, 2022 December 19, 2022Categories News StoriesBlinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL
December 15, 2022 December 15, 2022Categories News StoriesStudy E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)
December 14, 2022 December 14, 2022Categories News StoriesBlinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)
December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
